These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24681505)

  • 1. [Bone and Stem Cells. Advancement of regenerative medicine in the locomotive system using iPS cells].
    Toguchida J
    Clin Calcium; 2014 Apr; 24(4):587-92. PubMed ID: 24681505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes Secreted from Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Prevent Osteonecrosis of the Femoral Head by Promoting Angiogenesis.
    Liu X; Li Q; Niu X; Hu B; Chen S; Song W; Ding J; Zhang C; Wang Y
    Int J Biol Sci; 2017; 13(2):232-244. PubMed ID: 28255275
    [No Abstract]   [Full Text] [Related]  

  • 3. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?
    de Lázaro I; Yilmazer A; Kostarelos K
    J Control Release; 2014 Jul; 185():37-44. PubMed ID: 24746625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on viability and chondrogenic differentiation of cryopreserved adipose tissue-derived mesenchymal stromal cells for future use in regenerative medicine.
    González-Fernández ML; Pérez-Castrillo S; Ordás-Fernández P; López-González ME; Colaço B; Villar-Suárez V
    Cryobiology; 2015 Oct; 71(2):256-63. PubMed ID: 26209137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced Pluripotent Stem Cells as a new Strategy for Osteogenesis and Bone Regeneration.
    Lou X
    Stem Cell Rev Rep; 2015 Aug; 11(4):645-51. PubMed ID: 26022504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational Cell Therapies in Regenerative Medicine and Cancers.
    Lin SZ
    Cell Transplant; 2016; 25(5):781-2. PubMed ID: 27102174
    [No Abstract]   [Full Text] [Related]  

  • 7. Differentiation of hepatocytes from induced pluripotent stem cells derived from human hair follicle mesenchymal stem cells.
    Shi X; Lv S; He X; Liu X; Sun M; Li M; Chi G; Li Y
    Cell Tissue Res; 2016 Oct; 366(1):89-99. PubMed ID: 27053247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regenerative cells for transplantation in hepatic failure.
    Ishikawa T; Banas A; Teratani T; Iwaguro H; Ochiya T
    Cell Transplant; 2012; 21(2-3):387-99. PubMed ID: 22793046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose-derived stem cells: fatty potentials for therapy.
    Ong WK; Sugii S
    Int J Biochem Cell Biol; 2013 Jun; 45(6):1083-6. PubMed ID: 23458962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Therapeutic Applications of Induced Pluripotent Stem Cells.
    Rami F; Beni SN; Kahnamooi MM; Rahimmanesh I; Salehi AR; Salehi R
    Cell Reprogram; 2017 Apr; 19(2):65-74. PubMed ID: 28266864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of Musculoskeletal Systems and Their Diseases. Use of iPS cells in regenerative therapy and drug discovery for cartilage diseases].
    Tsumaki N
    Clin Calcium; 2015 Aug; 25(8):1162-8. PubMed ID: 26224673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human transgene-free amniotic-fluid-derived induced pluripotent stem cells for autologous cell therapy.
    Jiang G; Di Bernardo J; Maiden MM; Villa-Diaz LG; Mabrouk OS; Krebsbach PH; O'Shea KS; Kunisaki SM
    Stem Cells Dev; 2014 Nov; 23(21):2613-25. PubMed ID: 25014361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentialities of induced pluripotent stem (iPS) cells for treatment of diseases.
    Chakraborty C; Shah KD; Cao WG; Hsu CH; Wen ZH; Lin CS
    Curr Mol Med; 2010 Nov; 10(8):756-62. PubMed ID: 20937020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects of induced pluripotent stem cell technology in regenerative medicine.
    Zhang F; Citra F; Wang DA
    Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced pluripotent stem cells for cardiovascular disease: from product-focused disease modeling to process-focused disease discovery.
    Campbell KA; Terzic A; Nelson TJ
    Regen Med; 2015; 10(6):773-83. PubMed ID: 26439809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current status and perspective on regenerative medicine for spinal cord injury using iPS cell].
    Nakamura M; Toyama Y; Okano H
    Rinsho Shinkeigaku; 2013; 53(11):1013-5. PubMed ID: 24291863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.
    Pan G; Wang T; Yao H; Pei D
    Bioessays; 2012 Jun; 34(6):472-6. PubMed ID: 22419173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Mesenchymal Stem Cells in Bone Regenerative Medicine: What Is the Evidence?
    Oryan A; Kamali A; Moshiri A; Baghaban Eslaminejad M
    Cells Tissues Organs; 2017; 204(2):59-83. PubMed ID: 28647733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies.
    D'souza N; Rossignoli F; Golinelli G; Grisendi G; Spano C; Candini O; Osturu S; Catani F; Paolucci P; Horwitz EM; Dominici M
    BMC Med; 2015 Aug; 13():186. PubMed ID: 26265166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mesenchymal stem cells].
    Pojda Z; Machaj E; Kurzyk A; Mazur S; Debski T; Gilewicz J; Wysocki J
    Postepy Biochem; 2013; 59(2):187-97. PubMed ID: 24044283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.